Vfend

Vfend is a brand name of voriconazole, approved by the FDA in the following formulation(s):

VFEND (voriconazole - for suspension; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: December 19, 2003
  
  Strength(s): 200MG/5ML ^[RLD]

VFEND (voriconazole - injectable; iv (infusion))

• 
  Manufacturer: PFIZER
  
  Approval date: May 24, 2002
  
  Strength(s): 200MG/VIAL ^[RLD]

VFEND (voriconazole - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: May 24, 2002
  
  Strength(s): 200MG ^[RLD][AB], 50MG ^[AB]

Has a generic version of Vfend been approved?

A generic version of Vfend has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Vfend and have been approved by the FDA:

voriconazole tablet; oral

• 
  Manufacturer: MATRIX LABS LTD
  
  Approval date: April 22, 2010
  
  Strength(s): 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: SANDOZ INC
  
  Approval date: December 12, 2011
  
  Strength(s): 200MG ^[AB], 50MG ^[AB]

Note: No generic formulation of the following products are available.

• voriconazole - for suspension; oral


• voriconazole - injectable; iv (infusion)

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vfend. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Triazole antifungal agents
  Patent 5,364,938
  Issued: November 15, 1994
  Inventor(s): Dickinson; Roger P. & Richardson; Kenneth
  Assignee(s): Pfizer Inc.
  The invention provides antifungal agents of the formula: ##STR1## and their pharmaceutically acceptable salts, wherein R is phenyl optionally substituted by 1 to 3 substituents each independently selected from halo and CF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; and "Het", which is attached to the adjacent carbon atom by a ring carbon atom, is selected from pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl and triazinyl, "Het" being optionally substituted by C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, halo, CF.sub.3, CN, NO.sub.2, NH.sub.2, --NH(C.sub.1 -C.sub.4 alkanoyl) or --NHCO.sub.2 (C.sub.1 -C.sub.4 alkyl).
  
  Patent expiration dates:
  
  
  • November 15, 2011
    
    ✓ 
    Drug substance
  
  



• 
  Triazole antifungal agents
  Patent 5,567,817
  Issued: October 22, 1996
  Inventor(s): Ray; Stephen J. & Richardson; Kenneth
  Assignee(s): Pfizer Inc.
  The invention provides antifungal compounds of the formula: ##STR1## and pharmaceutical salts thereof, wherein R is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; X is CH or N; and Y is F or Cl.
  
  Patent expiration dates:
  
  
  • May 24, 2016
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical formulations containing voriconazole
  Patent 6,632,803
  Issued: October 14, 2003
  Inventor(s): Valerie Denise; Harding
  Assignee(s): Pfizer Inc
  The invention provides pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative thereof, and a sulfobutylether &bgr;-cyclodextrin.
  
  Patent expiration dates:
  
  
  • June 2, 2018
    
    ✓ 
    Drug product
  
  

See also...

• Vfend Consumer Information (Drugs.com)
• Vfend Consumer Information (Wolters Kluwer)
• Vfend Suspension Consumer Information (Wolters Kluwer)
• Vfend Tablets Consumer Information (Wolters Kluwer)
• VFEND Consumer Information (Cerner Multum)
• Vfend Advanced Consumer Information (Micromedex)
• Vfend Oral Advanced Consumer Information (Micromedex)
• Vfend AHFS DI Monographs (ASHP)
• Voriconazole Consumer Information (Wolters Kluwer)
• Voriconazole Suspension Consumer Information (Wolters Kluwer)
• Voriconazole Tablets Consumer Information (Wolters Kluwer)
• Voriconazole Consumer Information (Cerner Multum)
• Vfend I.V. Advanced Consumer Information (Micromedex)
• Voriconazole Advanced Consumer Information (Micromedex)
• Voriconazole Oral, Intravenous Advanced Consumer Information (Micromedex)
• Voriconazole AHFS DI Monographs (ASHP)

Ferrofumaraat Sandoz

Ferrofumaraat Sandoz may be available in the countries listed below.

Ingredient matches for Ferrofumaraat Sandoz

Ferrous Fumarate

Ferrous Fumarate is reported as an ingredient of Ferrofumaraat Sandoz in the following countries:

• Netherlands

International Drug Name Search

Pinex

Pinex may be available in the countries listed below.

Ingredient matches for Pinex

Paracetamol

Paracetamol is reported as an ingredient of Pinex in the following countries:

• Denmark


• Norway

International Drug Name Search

Noscapine Hydrochloride

Noscapine Hydrochloride may be available in the countries listed below.

Ingredient matches for Noscapine Hydrochloride

Noscapine

Noscapine Hydrochloride (BANM, JAN) is also known as Noscapine (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bio-Metronidazole

Bio-Metronidazole may be available in the countries listed below.

Ingredient matches for Bio-Metronidazole

Metronidazole

Metronidazole is reported as an ingredient of Bio-Metronidazole in the following countries:

• South Africa

International Drug Name Search

Be-Tabs Pyridoxine HCl

Be-Tabs Pyridoxine HCl may be available in the countries listed below.

Ingredient matches for Be-Tabs Pyridoxine HCl

Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Be-Tabs Pyridoxine HCl in the following countries:

• South Africa

International Drug Name Search

Glivec

Glivec may be available in the countries listed below.

UK matches:

• GLIVEC Tablets (SPC)

Ingredient matches for Glivec

Imatinib

Imatinib is reported as an ingredient of Glivec in the following countries:

• Tunisia


• Turkey

Imatinib mesilate (a derivative of Imatinib) is reported as an ingredient of Glivec in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nimesulide Actavis

Nimesulide Actavis may be available in the countries listed below.

Ingredient matches for Nimesulide Actavis

Nimesulide

Nimesulide is reported as an ingredient of Nimesulide Actavis in the following countries:

• Italy

International Drug Name Search

Labetalol Hydrochloride

Ingredient matches for Labetalol Hydrochloride

Labetalol

Labetalol Hydrochloride (BANM, JAN, USAN) is known as Labetalol in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Videne

Videne may be available in the countries listed below.

Ingredient matches for Videne

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Videne in the following countries:

• Hong Kong


• United Kingdom

International Drug Name Search

Cervagème

Cervagème may be available in the countries listed below.

Ingredient matches for Cervagème

Gemeprost

Gemeprost is reported as an ingredient of Cervagème in the following countries:

• France

International Drug Name Search

Endo+Lint

Endo+Lint may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Endo+Lint

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Endo+Lint in the following countries:

• South Africa

Praziquantel

Praziquantel is reported as an ingredient of Endo+Lint in the following countries:

• South Africa

International Drug Name Search

Mirtazapina Ratiomed

Mirtazapina Ratiomed may be available in the countries listed below.

Ingredient matches for Mirtazapina Ratiomed

Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapina Ratiomed in the following countries:

• Spain

International Drug Name Search

Nespo

Nespo may be available in the countries listed below.

Ingredient matches for Nespo

Darbepoetin Alfa

Darbepoetin Alfa is reported as an ingredient of Nespo in the following countries:

• Italy


• Slovakia

International Drug Name Search

Tofalcone

Tofalcone may be available in the countries listed below.

Ingredient matches for Tofalcone

Sofalcone

Sofalcone is reported as an ingredient of Tofalcone in the following countries:

• Japan

International Drug Name Search